This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Other diseases of pericardium심장막의 기타 질환 (심장막기타질환)

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: I31 (Other diseases of pericardium) | Special Copayment Reduction: V192 (Special copayment reduction for heart disease: 5% copayment for up to 30 days from the registration date)
B. SynonymsChronic constrictive pericarditis, pericardial effusion, pericardial tamponade, hemopericardium
C. Adult onsetChronic constrictive pericarditis mainly presents in middle-aged and older adults and appears as a result of pericardial fibrosis after tuberculosis, radiation, or surgery. Pericardial effusion and tamponade occur at various ages and can progress to an emergency.
1. HistoryDevelopment from Hippocrates' description of the pericardium, through Cheever's surgical treatment of constrictive pericarditis (1842), to modern pericardiectomy
2. CausesConstrictive pericarditis: idiopathic/viral (most common), tuberculosis, radiation, after cardiac surgery; pericardial effusion: neoplasm, infection, autoimmune
3. GeneticsMMP and TIMP gene polymorphisms are involved in the progression of pericardial fibrosis; tuberculosis-susceptibility HLA genotypes are associated with tuberculous constrictive pericarditis
4. General epidemiologyPrevalence of constrictive pericarditis about 0.1%; as a long-term complication of acute pericarditis, idiopathic is the most common cause in Western countries
5. PathophysiologyRestriction of ventricular filling by a fibrotic, rigid pericardium → reduced cardiac output → venous congestion; includes effusive-constrictive and transient constrictive subtypes
6. SymptomsSlowly progressive exercise intolerance, abdominal distension, lower extremity edema, fatigue; in pericardial tamponade, sudden dyspnea and hypotension develop
7. SignsKussmaul sign (JVP rise on inspiration), pericardial knock, pulsus paradoxus, diminished heart sounds, hepatomegaly, ascites, lower extremity edema
8. ScreeningLow voltage on ECG, pericardial calcification on chest X-ray, and diastolic abnormalities on echocardiography are used in screening for constrictive pericarditis
9. DiagnosisDefinitive diagnosis and differentiation by Doppler echocardiography, cardiac CT (pericardial thickness and calcification), CMR, and cardiac catheterization (pressure measurement)
10. TreatmentThe definitive treatment of constrictive pericarditis is pericardiectomy; pericardiocentesis for pericardial effusion and tamponade; NSAIDs and colchicine in the transient form
11. Prognosis5-year survival after pericardiectomy for constrictive pericarditis about 80%; radiation-induced and tuberculous forms have a worse prognosis than idiopathic
12. PreventionPrevention of transition to constriction through early and complete treatment of acute pericarditis; early treatment of tuberculosis; pericardial protection during radiotherapy
13. ReferencesBertog SC, et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy … and 9 other papers

1. History

The history of other diseases of the pericardium, especially chronic constrictive pericarditis, is also a history of a long-standing surgical challenge. In antiquity, Hippocrates described the existence of the pericardium and the fluid that collects within it, but it took hundreds of years for this to be recognized as an independent disease. In the 18th century, Richard Lower systematically described the function of the pericardium and the pathology of pericardial disease, and in the early 19th century, René Laennec linked the clinical features of constrictive pericarditis with its pathological findings.

Surgical treatment of constrictive pericarditis is recorded as beginning when Cheever first attempted pericardial incision in 1842. However, until the early 20th century, most surgical attempts failed with high mortality. In 1929, Churchill first successfully completed a pericardiectomy, and the surgical technique subsequently advanced through the contributions of Beck (1931) and Sauerbruch. The introduction of extracorporeal circulation (1953, Gibbon) further improved the safety of pericardiectomy.

Important advances have also been made in the treatment of pericardial effusion and pericardial tamponade. Pericardiocentesis was first performed in the 1840s, but it was performed blindly and had many complications. The introduction of echocardiography-guided pericardiocentesis (from the 1970s onward) dramatically improved its safety. The Mayo Clinic accumulated extensive pericardiocentesis experience from the 1990s, contributing to standardization of this procedure.

The concept of effusive-constrictive pericarditis was first described by Hancock in 1970. This is a condition in which pericardial effusion and pericardial constriction coexist, characterized by right atrial pressure remaining elevated even after pericardial drainage. A 2004 study by Sagrista-Sauleda et al. systematized the clinical characteristics and treatment direction of effusive-constrictive pericarditis. Recently, the concept of transient constrictive pericarditis has been established, and it has been recognized that reversible forms, in which the constrictive pattern is reversed by anti-inflammatory treatment, may account for about 10-40% of all constrictive pericarditis.

In modern practice, CMR and multidetector CT have become key tools for precise evaluation of pericardial thickness, calcification, and abnormalities of pericardial relaxation. These advances in imaging technology have greatly improved the accuracy of differentiating constrictive pericarditis from restrictive cardiomyopathy and have made it possible to identify treatable causes and establish tailored treatment plans.


2. Causes

The causes of the diseases included in ICD I31 vary by subcategory. The causes of chronic constrictive pericarditis (I31.1) in Western countries are, in order, idiopathic/viral, the most common at about 40-50%, followed by after cardiac surgery (about 20-25%), after radiotherapy (about 10-15%), tuberculosis (about 5-15%), infectious pericarditis (including purulent), trauma, neoplastic, and autoimmune diseases (SLE, RA). In Africa and South Asia, tuberculosis is the most common cause.

Causes of pericardial effusion (I31.3) include neoplastic (direct invasion or metastasis of malignant tumors, especially lung cancer, breast cancer, lymphoma) at about 20-25%, idiopathic at about 20%, infectious (viral, tuberculous, purulent) at about 15-20%, autoimmune diseases (SLE, RA) at about 10-15%, post-myocardial infarction (including Dressler syndrome) at about 10%, uremia at about 5-10%, and hypothyroidism at about 5%. The main causes of hemopericardium (I31.2) are ventricular free wall rupture (a complication of myocardial infarction), pericardial involvement by aortic dissection, trauma, and bleeding from tumors invading the pericardium. Cardiac tamponade (I31.4) occurs when pericardial effusion of any cause accumulates rapidly or in large volume. Malignancy is the most common cause, followed by idiopathic, radiation-induced, and renal failure.


3. Genetics

The genetic background of pericardial disease has not yet been sufficiently studied, but several important associations have been reported. Because pericardial fibrosis, which is involved in progression to constrictive pericarditis, relates to collagen metabolism and extracellular matrix remodeling, polymorphisms of the genes regulating it, MMP (matrix metalloproteinase) and TIMP (tissue inhibitor of metalloproteinase), may have an influence. There are studies showing that promoter polymorphisms of the MMP-1, MMP-9, and TIMP-1 genes are associated with susceptibility to fibrotic diseases.

In tuberculous constrictive pericarditis, genes related to tuberculosis susceptibility are important. HLA-DRB1 and HLA-DQB1 genotypes affect tuberculosis susceptibility, and polymorphisms of the IL-12, IFN-γ, and TNF-α genes, which determine the host immune response to Mycobacterium tuberculosis, may also be involved in the severity of tuberculous pericardial complications and the tendency toward fibrosis progression. In pericardial effusion due to malignancy, the genetic characteristics of the underlying cancer (e.g., presence of EGFR mutations in lung cancer, genotype of lymphoma) affect the tendency toward pericardial involvement and prognosis.

Genetic factors are also involved in the risk of developing radiation-induced pericardial disease. Carriers of ATM (ataxia-telangiectasia mutated) gene variants have increased radiosensitivity and a higher risk of pericardial fibrosis and cardiotoxicity after radiotherapy. In autoimmune-related pericardial disease, SLE and rheumatoid arthritis susceptibility genes (HLA-DR2, HLA-DR3, PTPN22, IRF5, STAT4, etc.) may be associated with the tendency toward pericardial involvement.


4. General epidemiology

Chronic constrictive pericarditis is a relatively rare disease, and its exact prevalence is difficult to determine. The rate of transition from acute pericarditis to constrictive pericarditis is reported to be about 0.5-1%. Constrictive pericarditis after cardiac surgery is an important cause in modern medicine, in which many open-heart surgeries are performed, occurring in about 0.3-0.5% postoperatively. Tuberculous constrictive pericarditis is the most common cause of constrictive pericarditis requiring surgery in countries where tuberculosis is prevalent, and transition to constriction develops in the long term in about 10-40% of patients with tuberculous pericarditis.

Pericardial effusion is a more common clinical situation; mild effusion is found in about 10-20% of hospitalized patients undergoing echocardiography. Clinically significant pericardial effusion is relatively common in patients with malignancy, renal failure, and autoimmune diseases. Pericardial tamponade is reported to occur in about 2 per 1,000 hospitalized patients, and cancer-related pericardial tamponade has been increasing recently. Hemopericardium mostly occurs as an emergency, with free wall rupture after myocardial infarction, aortic dissection, and trauma being the most common causes.

Constrictive pericarditis is about twice as common in men as in women and occurs mainly in adults in their 40s-60s. Radiation-induced pericardial disease can occur even 5-30 years after radiotherapy, so in some cases it develops decades later in young patients who received mediastinal radiotherapy for lymphoma or breast cancer.


5. Pathophysiology

The pathophysiology of constrictive pericarditis is that a rigid, fibrotic pericardium physically restricts diastolic filling of the ventricles. The normal pericardium is thin and elastic and does not interfere with cardiac motion, but when post-inflammatory fibrosis or calcification progresses, the pericardium thickens and stiffens, encasing the heart like a shell. As a result, diastolic filling of the ventricles is impeded by the external restrictive pressure of the pericardium (pericardial constraint), ventricular end-diastolic pressure rises, filling volume decreases, and cardiac output falls.

The characteristic hemodynamic finding of constrictive pericarditis is increased ventricular interdependence. Because the total blood volume of the two ventricles is limited within the rigid pericardium, increased right heart filling on inspiration shifts the ventricular septum toward the left ventricle, reducing left ventricular filling. This explains pulsus paradoxus, in which systolic blood pressure paradoxically falls on inspiration. The Kussmaul sign, in which the JVP does not fall but instead rises during inspiration when venous return increases, is specific to constrictive pericarditis.

Cardiac tamponade is a condition in which effusion in the pericardial cavity increases rapidly or accumulates in large volume, raising intrapericardial pressure and externally compressing cardiac filling. Depending on the compliance of the pericardial cavity, in acute hemorrhage (e.g., free wall rupture) even a small amount (200-300mL) of blood can cause abrupt tamponade, whereas slowly increasing effusions (e.g., tumor, hypothyroidism) can accumulate to 1,000mL or more without symptoms.

Effusive-constrictive pericarditis is a condition in which pericardial effusion and pericardial constriction coexist, characterized by intrapericardial pressure not decreasing substantially and right atrial pressure remaining high even after pericardiocentesis. It occurs after tuberculosis, radiation, neoplasm, or multiple episodes of acute pericarditis, and some cases require pericardiectomy. Transient constrictive pericarditis is a subtype in which pericardial edema in the early inflammatory stage temporarily causes constrictive physiology but improves reversibly with anti-inflammatory treatment.


6. Symptoms

Symptoms of chronic constrictive pericarditis often progress slowly over months to years, making early diagnosis difficult. The most common symptoms are progressive exercise intolerance and fatigue, a result of reduced cardiac output. Abdominal fullness, anorexia, and nausea arise from hepatic congestion and ascites due to right heart failure. Lower extremity edema progresses slowly and in severe cases develops into generalized edema (anasarca). Some patients first present with severe ascites accompanied by hyponatremia and are misdiagnosed with liver cirrhosis or liver cancer.

Chest pain is rare or mild in constrictive pericarditis, and dyspnea is often mild as well, reflecting the characteristic that left ventricular function is relatively well preserved. This is an important clue for differentiating constrictive pericarditis from other heart diseases. Orthopnea is also rare. In severe cases, it may present with a nephrotic syndrome-like clinical picture accompanied by pleural effusion, ascites, and generalized edema.

Pericardial tamponade causes various acute symptoms. In the acute form, sudden dyspnea, tachycardia, hypotension, anxiety, and chest tightness appear, rapidly progressing to cardiogenic shock. In the subacute form (slowly developing effusion), dyspnea worsens gradually and is more severe when lying down. Weakness, dizziness, and presyncope may also occur. Pericardial effusion itself is often asymptomatic when small and is discovered on incidental imaging.


7. Signs

The most specific physical finding of constrictive pericarditis is the Kussmaul sign, a paradoxical response in which the JVP, which normally falls on inspiration, instead rises or does not fall in constrictive pericarditis. This is because the increased venous return on inspiration cannot be accommodated within the rigid pericardium. A prominent Y descent appears in the jugular venous waveform (dip-plateau or square root sign). The pericardial knock is an early diastolic sound occurring when ventricular filling is abruptly halted by the rigid pericardium, earlier and sharper than an S3 gallop.

Pulsus paradoxus is a fall in systolic blood pressure of 10mmHg or more on inspiration, seen in pericardial tamponade and severe constrictive pericarditis. The classic triad of pericardial tamponade (Beck's triad) is hypotension, jugular venous distension, and diminished heart sounds. Abdominal findings include hepatomegaly (worsening jugular venous distension with abdominal pressure, positive hepatojugular reflux), ascites, and lower extremity edema. In constrictive pericarditis, the apical impulse may not be palpable or may show paradoxical inward motion during systole. Pulmonary crackles are rare, which helps differentiate it from left ventricular dysfunction.


8. Screening

In patients suspected of constrictive pericarditis (unexplained right heart failure, ascites, jugular venous distension), initial screening begins with plain chest radiography. Pericardial calcification is observed on chest X-ray in about 25-30%, and is better seen on fluoroscopy in anteroposterior positions. The cardiac silhouette is normal or slightly enlarged in constrictive pericarditis, and indirect findings of pleural effusion or ascites can also be identified.

On the 12-lead electrocardiogram, there are no findings specific to constrictive pericarditis, but P segment abnormalities, low voltage, electrical alternans of the QRS complex (mainly seen in pericardial tamponade), nonspecific ST-T changes, and atrial fibrillation may be observed. Electrical alternans arises in pericardial tamponade from the swinging motion of the heart (pendulum motion) within a large effusion. Urine protein, BUN, and creatinine are used for congestive nephropathy due to constrictive pericarditis and for differential diagnosis. Troponin measurement is used to evaluate whether pericardial effusion is accompanied by myocarditis.


9. Diagnosis

Transthoracic echocardiography (TTE) is the most important initial diagnostic tool for pericardial effusion and also provides characteristic findings in constrictive pericarditis. In constrictive pericarditis, abrupt cessation of ventricular filling with resulting rebound (septal bounce), respiratory ventricular interdependence (right ventricular dilation on inspiration + leftward shift of the ventricular septum), and a plethoric vena cava response (inferior vena cava distension + reduced inspiratory collapse) are characteristic. On tissue Doppler imaging (TDI), the absence of reduction or normal value of medial mitral annular e' velocity is also an important differentiating finding.

Cardiac CT excels at precisely measuring and visualizing pericardial thickness (normal <2mm, usually ≥4mm in constrictive pericarditis) and pericardial calcification. However, a normal pericardial thickness does not exclude constrictive pericarditis, and pericardial thickness may be measured as normal in about 20%. CMR comprehensively evaluates pericardial inflammation (LGE), thickness, and ventricular relaxation abnormalities, and also helps confirm pericardial adhesion. Cardiac catheterization is performed when needed for definitive diagnosis; equalization of end-diastolic pressures of both ventricles (equalization of diastolic pressures within 5mmHg) and a dip-plateau (square root sign) form of the right ventricular pressure curve are diagnostic. Simultaneous recording of left and right ventricular pressures is important for differentiation from restrictive cardiomyopathy.


10. Treatment

The definitive treatment of chronic constrictive pericarditis is pericardiectomy. It aims at the most extensive possible removal of the pericardium through a median sternotomy, and recovery of cardiac output may take several months after surgery. The appropriate timing of surgery is the stage at which symptoms are present and surgical risk is acceptable; with severe calcification or marked myocardial atrophy, technical difficulty increases and outcomes are poor. Surgical mortality is 6-12% and is higher in the elderly, NYHA functional class IV, and radiation-induced constrictive pericarditis.

In transient constrictive pericarditis, constrictive physiology can be reversed when inflammation is resolved with NSAIDs and colchicine. A trial of anti-inflammatory treatment (2-3 months) is attempted first, and surgery is considered if there is no improvement. In tuberculous constrictive pericarditis, the role of adjunctive corticosteroid therapy together with antituberculosis treatment is controversial, but it may be effective in some in suppressing fibrosis progression. The main treatment of pericardial effusion and tamponade is pericardiocentesis, performed safely under ultrasound guidance. A pericardial drain is temporarily left in place for continuous drainage. Surgical pericardial window is performed for recurrent malignant pericardial effusion or malignant pericardial effusion refractory to medical treatment.


11. Prognosis

The prognosis of constrictive pericarditis differs greatly by cause. Idiopathic/viral constrictive pericarditis has the best prognosis after pericardiectomy, with 5-year survival reaching about 80-90%. Constrictive pericarditis after cardiac surgery also shows relatively good results after pericardiectomy. In contrast, radiation-induced constrictive pericarditis is often accompanied by radiation-induced myocardial and coronary artery injury, so recovery of ventricular function is poor even after pericardiectomy, and 5-year survival is markedly lower at 40-60%.

In tuberculous constrictive pericarditis, complete antituberculosis treatment can suppress fibrosis progression, but if severe constrictive lesions have already formed, pericardiectomy is needed, and prognosis is determined by whether the cause is treated appropriately. The prognosis of pericardial effusion due to malignancy is determined by the type and extent of the underlying malignancy, with survival of several months generally expected overall. Symptoms can be relieved with repeated pericardiocentesis or pericardial window. When pericardial tamponade occurs, restoring hemodynamic stability with immediate pericardiocentesis is decisive for survival.


12. Prevention

Prevention of constrictive pericarditis is achieved above all through early and complete treatment of acute pericarditis. Colchicine is maintained fully for 3 months, and if anti-inflammatory treatment is incomplete or recurrences are repeated, the risk of fibrosis progression increases. Use of IL-1 inhibitors in recurrent pericarditis is being studied as a potential strategy to prevent pericardial fibrosis due to repeated inflammation. In tuberculous pericarditis, complete adherence to standard antituberculosis treatment is key to preventing transition to constriction. The preventive effect of adjunctive corticosteroid therapy has not yet been sufficiently proven but has been suggested in some studies.

Techniques to minimize cardiotoxicity during radiotherapy are important. In modern radiotherapy, respiratory control techniques (deep inspiration breath hold), intensity-modulated radiation therapy (IMRT), and proton therapy are applied to minimize cardiac dose. To prevent pericardial effusion and constrictive pericarditis after cardiac surgery, some surgeons use a strategy of performing a pericardial window simultaneously at the end of surgery. In patients with malignancy, early detection of pericardial effusion through regular echocardiographic follow-up and timely drainage prevent progression to tamponade.


13. References

  1. Bertog SC, Thambidorai SK, Parakh K, et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. Journal of the American College of Cardiology. 2004;43(8):1445-1452. DOI: 10.1016/j.jacc.2003.11.048. PMID: 15093882.

  2. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. European Heart Journal. 2015;36(42):2921-2964. DOI: 10.1093/eurheartj/ehv318. PMID: 26320112.

  3. Maisch B, Seferovic PM, Ristic AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary. European Heart Journal. 2004;25(7):587-610. DOI: 10.1016/j.ehj.2004.02.002. PMID: 15120056.

  4. Imazio M, Brucato A, Maestroni S, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011;124(11):1270-1275. DOI: 10.1161/CIRCULATIONAHA.111.018580. PMID: 21844077.

  5. Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation. 2010;121(7):916-928. DOI: 10.1161/CIRCULATIONAHA.108.844753. PMID: 20177006.

  6. Sagristà-Sauledà J, Mercé AS, Soler-Soler J. Diagnosis and management of pericardial effusion. World Journal of Cardiology. 2011;3(5):135-143. DOI: 10.4330/wjc.v3.i5.135. PMID: 21655139.

  7. Ling LH, Oh JK, Breen JF, et al. Calcific constrictive pericarditis: is it still with us? Annals of Internal Medicine. 2000;132(6):444-450. DOI: 10.7326/0003-4819-132-6-200003210-00004. PMID: 10733440.

  8. Talreja DR, Edwards WD, Danielson GK, et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 2003;108(15):1852-1857. DOI: 10.1161/01.CIR.0000087387.86507.4F. PMID: 14517170.

  9. Welch TD, Ling LH, Espinosa RE, et al. Echocardiographic diagnosis of constrictive pericarditis: Mayo Clinic criteria. Circulation: Cardiovascular Imaging. 2014;7(3):526-534. DOI: 10.1161/CIRCIMAGING.113.001613. PMID: 24647845.

  10. Cremer PC, Kumar A, Kontzias A, et al. Complicated pericarditis: understanding risk factors and pathophysiology to inform imaging and treatment. Journal of the American College of Cardiology. 2016;68(21):2311-2328. DOI: 10.1016/j.jacc.2016.07.785. PMID: 27884253.